Strong Association Between Weight Reduction and Suppression of Cardiovascular Events in Recent Clinical Trials of DPP4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors

Abstract

N/A




J Clin Med Res. 2018;10(10):796-797
doi: https://doi.org/10.14740/jocmr3587w